Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-24

Clinical Trial Update: Evaluation of Efficacy and Tolerabilty of MelaB3 Serum in Combination of 35% Glycolic Acid Peeling Compared to 35% Glycolic Acid Peeling Alone in Various Hyperpigmentation Conditions [NA]

View source ↗

Summary

The trial evaluates the efficacy and tolerability of MelaB3 Serum when combined with 35% glycolic acid peeling versus glycolic acid peeling alone for hyperpigme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MelaB3 Serum

Snippet

Sponsor: Cosmetique Active International | Conditions: Hyperpigmentation, Melasma | NA | Status: NOT_YET_RECRUITING